These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35497783)

  • 21. Therapeutic Advances in Diabetic Nephropathy.
    Sawaf H; Thomas G; Taliercio JJ; Nakhoul G; Vachharajani TJ; Mehdi A
    J Clin Med; 2022 Jan; 11(2):. PubMed ID: 35054076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of renin-angiotensin-aldosterone system blockade in adults with diabetes mellitus and advanced chronic kidney disease not on dialysis: a systematic review and meta-analysis.
    Nistor I; De Sutter J; Drechsler C; Goldsmith D; Soler MJ; Tomson C; Wiecek A; Donciu MD; Bolignano D; Van Biesen W; Covic A
    Nephrol Dial Transplant; 2018 Jan; 33(1):12-22. PubMed ID: 29106631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacotherapy to delay the progression of diabetic kidney disease in people with type 2 diabetes: past, present and future.
    Mallik R; Chowdhury TA
    Ther Adv Endocrinol Metab; 2022; 13():20420188221081601. PubMed ID: 35281302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis 101: diabetic kidney disease.
    Lerma EV
    Clin Kidney J; 2022 Oct; 15(10):1797-1799. PubMed ID: 36158143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on role of direct renin inhibitor in diabetic kidney disease.
    Dhakarwal P; Agrawal V; Kumar A; Goli KM; Agrawal V
    Ren Fail; 2014 Jul; 36(6):963-9. PubMed ID: 24678880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Managing diabetic kidney disease.
    Zac-Varghese S; Winocour P
    Br Med Bull; 2018 Mar; 125(1):55-66. PubMed ID: 29216336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathophysiologic mechanisms in diabetic kidney disease: A focus on current and future therapeutic targets.
    Barrera-Chimal J; Jaisser F
    Diabetes Obes Metab; 2020 Apr; 22 Suppl 1():16-31. PubMed ID: 32267077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. To RAS or not to RAS? The evidence for and cautions with renin-angiotensin system inhibition in patients with diabetic kidney disease.
    St Peter WL; Odum LE; Whaley-Connell AT
    Pharmacotherapy; 2013 May; 33(5):496-514. PubMed ID: 23576066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential of Renin-Angiotensin-Aldosterone System Modulations in Diabetic Kidney Disease: Old Players to New Hope!
    Malek V; Suryavanshi SV; Sharma N; Kulkarni YA; Mulay SR; Gaikwad AB
    Rev Physiol Biochem Pharmacol; 2021; 179():31-71. PubMed ID: 32979084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update of pathophysiology and management of diabetic kidney disease.
    Lin YC; Chang YH; Yang SY; Wu KD; Chu TS
    J Formos Med Assoc; 2018 Aug; 117(8):662-675. PubMed ID: 29486908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of renin-angiotensin-aldosterone system blockers on the progression of chronic kidney disease in hypertensive elderly patients without proteinuria: PROERCAN study. Rationale and design.
    García-Prieto AM; Verdalles Ú; de José AP; Verde E; Arroyo D; Aragoncillo I; Linares T; Barbieri D; Goicoechea M
    Hipertens Riesgo Vasc; 2020; 37(3):101-107. PubMed ID: 32156479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mineralcorticoid receptor blockers in chronic kidney disease.
    Erraez S; López-Mesa M; Gómez-Fernández P
    Nefrologia (Engl Ed); 2021; 41(3):258-275. PubMed ID: 33358451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease.
    Zou H; Zhou B; Xu G
    Cardiovasc Diabetol; 2017 May; 16(1):65. PubMed ID: 28511711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic Kidney Disease and SGLT2 Inhibitors: A Review of the Evolving Treatment Landscape.
    Mende CW
    Adv Ther; 2022 Jan; 39(1):148-164. PubMed ID: 34846711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of Type 2 Diabetic Kidney Disease in 2022: A Narrative Review for Specialists and Primary Care.
    Cherney DZI; Bell A; Girard L; McFarlane P; Moist L; Nessim SJ; Soroka S; Stafford S; Steele A; Tangri N; Weinstein J
    Can J Kidney Health Dis; 2023; 10():20543581221150556. PubMed ID: 36726361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aortic stiffness and ambulatory blood pressure as predictors of diabetic kidney disease: a competing risks analysis from the Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Salles GC; Ferreira MT; Salles GF
    Diabetologia; 2018 Feb; 61(2):455-465. PubMed ID: 29063128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-World Diagnosis and Treatment of Diabetic Kidney Disease.
    Rodriguez F; Lee DJ; Gad SS; Santos MP; Beetel RJ; Vasey J; Bailey RA; Patel A; Blais J; Weir MR; Dash R
    Adv Ther; 2021 Aug; 38(8):4425-4441. PubMed ID: 34254257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of sodium-glucose co-transporter-2 inhibitors in Asian patients with type 2 diabetes and kidney disease: An Asian perspective and expert recommendations.
    Khoo CM; Deerochanawong C; Chan SP; Matawaran B; Sheu WH; Chan J; Mithal A; Luk A; Suastika K; Yoon KH; Ji L; Man NH; Pollock C
    Diabetes Obes Metab; 2021 Feb; 23(2):299-317. PubMed ID: 33155749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kidney Disease in Type 2 Diabetes Mellitus and Benefits of Sodium-Glucose Cotransporter 2 Inhibitors: A Consensus Statement.
    Roy A; Maiti A; Sinha A; Baidya A; Basu AK; Sarkar D; Sanyal D; Biswas D; Maisnam I; Pandit K; Raychaudhuri M; Sengupta N; Chakraborty PP; Mukhopadhyay P; Raychaudhuri P; Sahana PK; Chatterjee P; Bhattacharjee R; Dasgupta R; Saraogi RK; Pal SK; Mukhopadhyay S; Mukhopadhyay S; Goswami S; Chowdhury S; Ghosh S;
    Diabetes Ther; 2020 Dec; 11(12):2791-2827. PubMed ID: 33025397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.